AU2002334916A1 - Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) - Google Patents

Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)

Info

Publication number
AU2002334916A1
AU2002334916A1 AU2002334916A AU2002334916A AU2002334916A1 AU 2002334916 A1 AU2002334916 A1 AU 2002334916A1 AU 2002334916 A AU2002334916 A AU 2002334916A AU 2002334916 A AU2002334916 A AU 2002334916A AU 2002334916 A1 AU2002334916 A1 AU 2002334916A1
Authority
AU
Australia
Prior art keywords
tace
tnf
inhibitors
converting enzyme
matrix metalloproteinases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002334916A
Inventor
Jingwu Duan
Chu-Biao Xue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU2002334916A1 publication Critical patent/AU2002334916A1/en
Abandoned legal-status Critical Current

Links

AU2002334916A 2001-10-09 2002-10-07 Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace) Abandoned AU2002334916A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60/327,816 2001-10-09

Publications (1)

Publication Number Publication Date
AU2002334916A1 true AU2002334916A1 (en) 2003-04-22

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003282920A1 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
AU2002357312A1 (en) Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases
AU2002341715A1 (en) Cyclic hydroxamic acids as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
AU2003220401A1 (en) Uracil derivatives as inhibitors of tnf-alpha converting enzyme (tace) and matrix metalloproteinases
AU2002324716A1 (en) Bicyclic hydroxamates as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
AU2003261214A1 (en) Use of printing and other technology for micro-component placement
AU2003249549A1 (en) Generalized metronome for modification of biorhythmic activity
AU2003263345A1 (en) Sulphonamide derivatives and their use as tace inhibitors
AU2002251266A1 (en) Inhibitors of akt activity
AU2002357882A1 (en) Small-molecule inhibitors of interleukin-2
AU2003261319A1 (en) Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
AU2002346729A1 (en) Barbituric acid derivatives as inhibitors of tnf-$g(a) converting enzyme (tace) and/or matrix metalloproteinases
AU2002365132A1 (en) BICYCLIC LACTAM DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES AND/OR TNF-Alpha CONVERTING ENZYME (TACE)
AU2001265182A1 (en) Inhibitors of matrix metalloproteinases
AU2003301903A1 (en) Isoxazoline derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme
AU2003217916A1 (en) Stable formulations of angiotensin converting enzyme (ace) inhibitors
AU2002246983A1 (en) 1,2-disubstituted cyclic inhibitors of matrix metallorproteases and tnf-alpha
AU2002338734A1 (en) Use of phosphorodiesterase IV inhibitors
AU2002334916A1 (en) Cyclic sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-$g(a) converting enzyme (tace)
AU2001274344A1 (en) Tissue inhibitors of matrix metalloproteinases
AU2002236120A1 (en) Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
AU2002359347A1 (en) Beta-sulfone derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace)
AU2002352696A1 (en) Cell substrates and methods of use thereof
AU2003224874A1 (en) INHIBITORS OF SERINE AND METALLO-ss-LACTAMASES
AU2002305868A1 (en) Inhibitors of reggamma